Koninklijke Philips NV RYLPF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RYLPF is a good fit for your portfolio.
News
-
Philips shares soar 30% after U.S. litigation settlement far lower than feared
-
Trending: Philips in Final Agreement With DOJ, FDA on Ventilators
-
Philips shares climb after finalizing pact with U.S. over device sales
-
Philips Reaches Final Pact With DoJ, FDA on Ventilator Recall — Update
-
Philips to halt CPAP sales in the U.S. as it takes $393 million provision
-
Trending: Philips Shares Drop After Suspends Sales of Sleep Apnea Devices in the U.S.
-
Philips Reaches Agreement With FDA on Ventilator Recall — 2nd Update
-
Philips Reaches Agreement With FDA on Ventilator Recall — Update
Trading Information
- Previous Close Price
- $26.32
- Day Range
- $25.90–25.96
- 52-Week Range
- $17.19–28.02
- Bid/Ask
- $24.69 / $26.76
- Market Cap
- $24.33 Bil
- Volume/Avg
- 1,519 / 30,187
Key Statistics
- Price/Earnings (Normalized)
- 18.70
- Price/Sales
- 1.30
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 2.97%
Company Profile
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Around 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Large Core
- Total Number of Employees
- 73,712
- Website
- https://www.philips.com
Competitors
Valuation
|
Metric
|
RYLPF
|
GE
|
SIE
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.70 | 43.88 | 17.85 |
Price/Book Value | 1.83 | 9.90 | 2.90 |
Price/Sales | 1.30 | 3.41 | 1.75 |
Price/Cash Flow | 27.30 | 32.47 | 11.81 |
Price/Earnings
RYLPF
GE
SIE
Financial Strength
|
Metric
|
RYLPF
|
GE
|
SIE
|
|---|---|---|---|
Quick Ratio | 0.74 | 0.81 | 1.07 |
Current Ratio | 1.20 | 1.14 | 1.41 |
Interest Coverage | −1.60 | 5.50 | 5.75 |
Quick Ratio
RYLPF
GE
SIE
Profitability
|
Metric
|
RYLPF
|
GE
|
SIE
|
|---|---|---|---|
Return on Assets (Normalized) | — | 0.27% | 4.09% |
Return on Equity (Normalized) | — | 1.53% | 12.81% |
Return on Invested Capital (Normalized) | — | 1.30% | 5.07% |
Return on Assets
RYLPF
GE
SIE
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Npdwzpdtp | Yxctr | $183.1 Bil | |||
| Stryker Corp
SYK
| Hpmlntypl | Mywcf | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Hbdycrmj | Wclmxwc | $110.1 Bil | |||
| Medtronic PLC
MDT
| Mvxjtcfh | Xxmxsw | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Znlyytsx | Xqxlk | $37.6 Bil | |||
| DexCom Inc
DXCM
| Ntwnkwdy | Ghnk | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Wyssrjyd | Vqnzlnb | $24.1 Bil | |||
| Steris PLC
STE
| Dbhfqwkp | Mcxyw | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Qylwmyzv | Gtwv | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Yjzvzwlf | Zrvlcy | $16.6 Bil |